Search Results 11-20 of 15440 for pharmacogenetics
Participation eligibility · Ages 18 and older. · Hospitalized on Generose 2E (Acute Care Psychiatry), 3E (Medical and Geriatric Psychiatry), or 3W (Mood ...
Cummins to a research career focused on HIV. Now he hopes that pharmacogenetics — the study of how genes affect a person's response to drugs — can improve the ...
Pharmacogenetics. If you have a particular health condition or disease, this type of genetic testing may help determine what medication and dosage will be ...
The Pharmacogenomics Lab under Richard Weinshilboum, Ph.D., investigates treatments for breast cancer, childhood leukemia, alcoholism and depression.
Mayo Clinic School of Health Sciences offers a 12-month PGY-2 Clinical Pharmacogenomics Residency in Rochester, Minnesota.
This study will use a 22 gene pharmacogenomics panel on 30 children with persistent Gastroesophageal Reflux Disease (GERD) who have not responded to therapy.
So this is a field of pharmacogenetics, and in this post-Human Genome Project era, it's become pharmacogenomics, meaning that we don't just focus in on a ...
Dr. Wang's Pharmacogenomics and Drug Targets Lab studies the relationship of genetic variation to responses of individual patients to cancer therapies.
PharmGKB and the Clinical Pharmacogenetics Implementation Consortium. Find evidence-based recommendations for gene-drug interactions. Food and Drug ...
New pharmacogenetics program offers local hospital differentiation. Karl E. Bushman, M.D., FACP, speaks to a patient about pharmacogenomics options. After St ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift now and help create new and better solutions for more than 1.3 million patients who turn to Mayo Clinic each year.